ClinicalTrials.govpublic full text
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose
tetanus, diphtheria, haemophilus influenzae type b, hepatitis b, poliomyelitis, acellular pertussis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 272399
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.